161 related articles for article (PubMed ID: 36719290)
1. Focused Ultrasound-mediated Liquid Biopsy in a Tauopathy Mouse Model.
Pacia CP; Yuan J; Yue Y; Leuthardt EC; Benzinger TLS; Nazeri A; Chen H
Radiology; 2023 Apr; 307(2):e220869. PubMed ID: 36719290
[TBL] [Abstract][Full Text] [Related]
2. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA.
Pacia CP; Yuan J; Yue Y; Xu L; Nazeri A; Desai R; Gach HM; Wang X; Talcott MR; Chaudhuri AA; Dunn GP; Leuthardt EC; Chen H
Theranostics; 2022; 12(1):362-378. PubMed ID: 34987650
[TBL] [Abstract][Full Text] [Related]
3. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
[TBL] [Abstract][Full Text] [Related]
4. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
[TBL] [Abstract][Full Text] [Related]
5. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
Ono M; Komatsu M; Ji B; Takado Y; Shimojo M; Minamihisamatsu T; Warabi E; Yanagawa T; Matsumoto G; Aoki I; Kanaan NM; Suhara T; Sahara N; Higuchi M
Aging Cell; 2022 Jul; 21(7):e13615. PubMed ID: 35662390
[TBL] [Abstract][Full Text] [Related]
6. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
7. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
Ahmad F; Mein H; Jing Y; Zhang H; Liu P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
[TBL] [Abstract][Full Text] [Related]
8. Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy.
Lyons CE; Graves SI; Razzoli M; Jeganathan K; Mansk RP; McGonigle S; Sabarinathan N; van Deursen JM; Baker DJ; Bartolomucci A
Psychosom Med; 2024 Jun; 86(5):366-378. PubMed ID: 37910129
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
[TBL] [Abstract][Full Text] [Related]
10. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH
Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120
[TBL] [Abstract][Full Text] [Related]
11. Characterization of
Weng CC; Hsiao IT; Yang QF; Yao CH; Tai CY; Wu MF; Yen TC; Jang MK; Lin KJ
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290239
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice.
Yukawa K; Yamamoto-Mcguire S; Cafaro L; Hong C; Kamme F; Ikezu T; Ikezu S
Acta Neuropathol Commun; 2023 Oct; 11(1):166. PubMed ID: 37853497
[TBL] [Abstract][Full Text] [Related]
13. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
14. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
Robert A; Schöll M; Vogels T
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200180
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
[TBL] [Abstract][Full Text] [Related]
16. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.
De Jesús-Cortés HJ; Nogueras-Ortiz CJ; Gearing M; Arnold SE; Vega IE
Neuroreport; 2012 Nov; 23(16):942-6. PubMed ID: 22975846
[TBL] [Abstract][Full Text] [Related]
17. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
18. Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Zaki MO; El-Desouky S; Elsherbiny DA; Salama M; Azab SS
Inflammopharmacology; 2022 Oct; 30(5):1871-1890. PubMed ID: 35922737
[TBL] [Abstract][Full Text] [Related]
19. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
[TBL] [Abstract][Full Text] [Related]
20. Seed-competent tau monomer initiates pathology in a tauopathy mouse model.
Mirbaha H; Chen D; Mullapudi V; Terpack SJ; White CL; Joachimiak LA; Diamond MI
J Biol Chem; 2022 Aug; 298(8):102163. PubMed ID: 35750209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
